RIFLE:a Phase Ⅱ trial of stereotactic ablative radiotherapy combined with fruquintinib and tislelizumab in metastatic colorectal cancer
Kun Wang
Yajie Chen
Zhiyuan Zhang
Ruiyan Wu
Menglong Zhou
Wang Yang
Juefeng Wan
Lijun Shen
Hui Zhang
Yan Wang
Xu Han
Jiazhou Wang
Zhen Zhang
Fan Xia
Keywords：metastatic colorectal cancerSABRimmunotherapy
Publication Date：2024-06-30
Online Publishing Date：2026-07-17(First online date of this platform, not the publication date of the document)
Pages：8( 231-238 )